Cargando…
The COVID-19 Pandemic Is Associated with Reduced Survival after Pancreatic Ductal Adenocarcinoma Diagnosis: A Single-Centre Retrospective Analysis
The COVID-19 pandemic has hugely disrupted healthcare provision, including oncology services. To evaluate the effects of the pandemic on referral routes leading to diagnosis, treatments, and prognosis in patients with pancreatic ductal adenocarcinoma, we performed a retrospective cohort study at a s...
Autores principales: | Madge, Oliver, Brodey, Alexandra, Bowen, Jordan, Nicholson, George, Sivakumar, Shivan, Bottomley, Matthew J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9105306/ https://www.ncbi.nlm.nih.gov/pubmed/35566700 http://dx.doi.org/10.3390/jcm11092574 |
Ejemplares similares
-
The COVID-19 pandemic is associated with a change in origin of pathways to diagnosis of pancreatic cancer: a single-centre retrospective analysis
por: Madge, Oliver, et al.
Publicado: (2022) -
Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
por: Chouari, Tarak, et al.
Publicado: (2023) -
Immunophenotypes of pancreatic ductal adenocarcinoma: Meta‐analysis of transcriptional subtypes
por: de Santiago, Ines, et al.
Publicado: (2019) -
Reducing nihilism in metastatic pancreatic ductal adenocarcinoma: Treatment, sequencing, and effects on survival outcomes
por: O'Reilly, Eileen M., et al.
Publicado: (2020) -
Pseudotime dynamics of T cells in pancreatic ductal adenocarcinoma inform distinct functional states within the regulatory and cytotoxic T cells
por: Jainarayanan, Ashwin, et al.
Publicado: (2023)